Change & Innovation Online Course(s) & Continuing Education
Access the latest clinical skills and research for Change & Innovation for NEONATOLOGY professional training. These Change & Innovation online courses provide practice-changing skills and valuable perspectives from leading global experts. This Change & Innovation education has been accredited for a variety of CEUs / CERPs and can be accessed on-demand, at your own pace.
Madge E. Buus-Frank DNP, APRN-BC, FAAN is a nurse practitioner, healthcare improvement scientists and scholar who has been actively engaged in both providing and improving healthcare for nearly 4 decades. Dr. Buus-Frank joined Dartmouth Hitchcock Medical Center in 1990 as one of the first acute care nurse practitioners in the Intensive Care Nursery where she played a pivotal role in building a team of NNPs to serve the Intensive Care Nursery in Lebanon, Nashua, and Manchester. Madge continues to serve as a clinical faculty member in the Department of Pediatrics at the Geisel School of Medicine at Dartmouth and remains invigorated by her clinical practice at the Children’s Hospital at Dartmouth (CHaD) where she has practiced for 30+ years.
Dr. Buus-Frank has been an early innovator on the front lines of developing and testing Learning Health Systems focused on coproducing care with patients and families. as well as improving education and research along the way. In 2019 Dr. Buus-Frank joined The Dartmouth Institute as a Senior Scientist. Her implementation science work currently focuses on a partnership between Dartmouth Hitchcock Health and The Dartmouth Institute, to deliver on the DHH strategic plan, called “The Promise.” She is a co-primary investigator leading a team that is testing the impact of a Learning Health System approach to accelerate co-production of care, to improve the experience of care for our patients and our people and our system. The LHS testing is currently underway in the oncology setting and we will be using whole system measures to evaluate the impact of the Learning health system on patient and family outcomes, cost and value, and research, scholarship and education. Additionally Dr. Buus-Frank serves on a TDI team supporting the Crohn’s & Colitis Foundation’s growing quality improvement collaborative (Qorus) serving as a ead curriculum consultant.
Dr. Buus-Frank is the immediate past Executive Vice President of the Vermont Oxford Network (VON), one of the world’s largest healthcare data and improvement networks in the world. At VON she collaborated with international faculty to conceptualize, design and executed large-scale multi-center quality improvement collaboratives, and massive on-line courses (MOOCs) , bringing >700 hospitals, states and health systems together to learn, share, measure and improve the quality, safety and value of care. Additionally, Dr. Buus-Frank championed and led the development of partnerships with state perinatal quality improvement collaboratives where she built both the common will and capacity to conduct audits and embrace e-based educational implementation packages allowing VON to scale the learning from center level improvement to achieve population-wide results using robust on-line educational technology and learning programs.
Dr. Buus-Frank was the Founding Editor-in-Chief for Advances in Neonatal Care: The Official Journal of the National Association of Neonatal Nurses, a peer-reviewed publication dedicated to advancing the art and science of neonatal care, serving for 5 years in this capacity. She was honored by NANN with a Lifetime Achievement Award in 2021. She is the author of numerous peer-reviewed publications and has been inducted as a Fellow of the American Academy of Nursing (FAAN) for her pioneering work in the field of neonatal care and improvement science.
Join your colleagues for a whirlwind journey of the past 20 years of neonatal care. Together we will reflect on key lessons from the past, identify opportunities to improve care in the present and reimagine how we might provide care to create a preferred future that fosters better health and outcomes for every baby, every time, and everywhere.
The Classics Versus New and Upcoming Therapies: Which is Better for Neonatal Seizures?
M. Petrea Cober, PharmD, BCNSP, BCPPS, FASPEN, attended the University of Tennessee, College of Pharmacy in Memphis, Tennessee. She completed her PGY1 Pharmacy Residency at Penn State Milton S. Hershey Medical Center in Hershey, Pennsylvania, and her PGY2 Pharmacy Residency in Pediatrics at the University of Michigan Hospitals and Health System in Ann Arbor, Michigan. She is currently the Clinical Pharmacy Specialist - Neonatal Intensive Care Unit and PGY1 Residency Program Director at Akron Children's Hospital where she provides clinical services and precepts pharmacy students and PGY1 pharmacy residents. She is also a Professor in the Department of Pharmacy Practice at Northeast Ohio Medical University (NEOMED). Her didactic teaching is in the areas of pediatrics, women’s health, and nutrition. She was awarded the 2021 Stanley Serlick Award from the American Society for Parenteral and Enteral Nutrition (ASPEN) recognizing her contributions to parenteral nutrition safety and serves as the current Chair-elect of the ASPEN Parenteral Nutrition Safety Committee.
The lifetime risk of seizures is highest in the neonatal period. While the etiology of neonatal seizures is commonly the result of acute brain injury, other possibilities exist. Unfortunately, the need to treat neonatal seizures with anti-epileptic therapies or the timing and duration of therapeutic management is still vastly unknown. While phenobarbital has long been considered the mainstay of first-line medical therapy for neonatal seizures, newer agents are increasing in their popularity due to fewer side effects and concerns regarding potential neuronal apoptosis with phenobarbital. This presentation will discuss the etiology, need and timing for therapeutic management, compare and contrast various anti-epileptic therapies, and first-line, second-line, and therapies following initial failure for neonatal seizures.
Using Your Voice to Drive Change – How Formal and Informal Nurse Leaders Make a Difference in The NICU
Pamela Spivey is an Advanced Practice Registered Nurse and founder of Spivey Consulting, LLC. She shares her 34 years of expertise in neonatal nursing and leadership development as a national speaker, author and certified leadership coach. Pam launched her own business in 2015 to support individual clients and corporate teams through professional coaching, leadership development, and consultative services. Her unique experiences and passion for caring, drives her to “help nurses away from the wall and toward their possibilities”.
Innovation and change is a constant in healthcare. Nurses are key stakeholders in developing, implementing and executing these changes. Whether the nurse is a formal or informal leader, their presence is vital for effective change. A nurse’s voice, your voice, can drive change by leading, guiding and engaging colleagues in the process. Extraordinary outcomes can be achieved with a clearly articulated vision, an inspired team, knowledge about the change (the why behind the what), and the resources necessary to create change. This presentation focuses on how leaders can prepare for change, move forward using change management strategies and sustain meaningful change in their units. Individual and collective strengths required to lead change will be shared.
View Details / Enroll
